SUPPLEMENTARY RESULTS
Supplementary Figure 1. T7 endonuclease assay reveals an enrichment of p53 mutated cells by nutlin but not RITA. Genomic DNA from HCT116 and H460 that was analyzed by next generation sequencing in Fig. 1c was PCR amplified using primers spanning the CRISPR nuclease target sites in TP53 exon 3 (ex3) or exon 5 (ex5). Ctrl, control cells not transfected with CRISPR nucleases; e3/e5.1/e5.2, cells transfected with CRISPR nucleases targeting the indicated TP53 sequences. Following denaturation, reannealing and incubation with T7 endonuclease PCR products were separated on agarose gels to visualize cleavage of heteroduplices as an indication for the presence of mutations. Figure 2 . Enrichment of cells depleted of p53 by RNAi. left: Western Blot of HCT116 cells transduced with indicated lentiviral constructs co-expressing shRNAs together with a secreted luciferase (GLuc or CLuc) and treated as indicated (N, 10 µM nutlin; R, 1 µM RITA). nsh, non-targeting control shRNA, shp53.1/5, p53-targeting shRNAs. right: mean fold enrichment of p53-knockdown (p53-kd) cells from 1:1 mixtures of CLuc-positive nsh cells with GLuc-positive cells expressing p53-shRNAs treated as indicated. Mean enrichment was calculated based on luciferase activities in the supernatant of triplicate cell mixtures (n=3) and tested for significant differences between treated and untreated groups by two-way ANOVA corrected for multiple comparisons by Dunnett's test (****, P<0.0001; n.s., not significant). 
Supplementary

